Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1957;17(6):979–989.

Inactivation of poliovirus by formaldehyde

Theoretical and practical aspects

Sven Gard
PMCID: PMC2537623  PMID: 13511143

Abstract

Since formaldehyde, either alone or in combination with other inactivating agents, is at present used in the production of all so-called “killed” poliovirus vaccines, a thorough knowledge of the kinetics of the reaction between the chemical agent and the virus, and of the mechanisms involved, is of great practical importance. In this paper the problem is discussed against the background of present knowledge of the structure of the virus and the chemical nature of the action of formaldehyde.

Full text

PDF
982

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. GARD S., LYCKE E., OLIN G., WESSLEN T. Inactivation of poliomyelitis virus by formaldehyde. Arch Gesamte Virusforsch. 1957;7(2):125–135. doi: 10.1007/BF01241813. [DOI] [PubMed] [Google Scholar]
  2. GIERER A., SCHRAMM G. Infectivity of ribonucleic acid from tobacco mosaic virus. Nature. 1956 Apr 14;177(4511):702–703. doi: 10.1038/177702a0. [DOI] [PubMed] [Google Scholar]
  3. HAAS R., KORNER L., DOSTAL V., SCHWEINSBERG H. Uber die Inaktivierung von Poliomyelitisviren mit Formaldehyd. Z Hyg Infektionskr. 1957;143(5):490–512. [PubMed] [Google Scholar]
  4. HOOK A. E., KUPSKY C. H., MCLEAN I. W., Jr, TIMM E. A. The nature of the formalin inactivation of poliomyelitis virus. J Immunol. 1956 Dec;77(6):444–452. [PubMed] [Google Scholar]
  5. LYCKE E., MELEN B., WRANGE G. Studies of the inactivation of poliomyelitis virus by formaldehyde. Arch Gesamte Virusforsch. 1957;7(4):378–383. doi: 10.1007/BF01240745. [DOI] [PubMed] [Google Scholar]
  6. SALK J. E. Considerations in the preparation and use of poliomyelitis virus vaccine. J Am Med Assoc. 1955 Aug 6;158(14):1239–1248. doi: 10.1001/jama.1955.02960140001001. [DOI] [PubMed] [Google Scholar]
  7. SALK J. E., KRECH U., YOUNGNER J. S., BENNETT B. L., LEWIS L. J., BAZELEY P. L. Formaldehyde treatment and safety testing of experimental poliomyelitis vaccines. Am J Public Health Nations Health. 1954 May;44(5):563–570. doi: 10.2105/ajph.44.5.563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. SCHWERDT C. E., SCHAFFER F. L. Some physical and chemical properties of purified poliomyelitis virus preparations. Ann N Y Acad Sci. 1955 Sep 27;61(4):740-50; discussion, 750-3. doi: 10.1111/j.1749-6632.1955.tb42530.x. [DOI] [PubMed] [Google Scholar]
  9. TAYLOR A. R., MCCORMICK M. J. Electron microscopy of poliomyelitis virus. Yale J Biol Med. 1956 Jun;28(6):589–597. [PMC free article] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES